For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
The best medicines for chronic low back pain: What does scientific evidence tell us?
+Print Archive
PRACTICE
The best medicines for chronic low back pain: What does scientific evidence tell us?
Wednesday 11 December 2019, 01:00 AM

Low back pain is the leading cause of disability worldwide, with effects on wellbeing and daily functioning
PHARMACOTHERAPY
This article, the second in a new column provided by prescribing pharmacists, discusses the complexities of treating chronic low back pain with pharmacological approaches
Key points, After non-pharmacological therapy, NSAIDs are recommended as first-line pharmacological therapy for low back pain.
Although the evidence for amitri
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.